Homepage

BioLaurus- A Molecular Imaging CRO

  • NASH Model: Ultrasound Imaging of Liver Fibrosis
    NASH Model: Ultrasound Imaging of Liver Fibrosis

MOLECULAR IMAGING SOLUTIONS

BioLaurus is a pre-clinical integrated molecular imaging research services provider to the biotech/pharma Industry. We’re working with leading biotech and pharmaceutical companies to accelerate their drug/device discovery and development stage research.

From consulting on study design through project execution, BioLaurus is focused on solutions that accelerate your research. Whether in vivo imaging on rodents, larger animals, or non-human primates we are there with you from start to finish. Our collaborative approach leverages your expertise and ours to create the optimum study. We use a CRO Network business model that leverages key partnerships to maximize resources and minimize costs. We work with BioLaurus approved and AAALAC accredited and USDA registered vivarium along with and a team of in-house experts and consultants.

We conduct research in the major preclinical R&D segments of drug discovery and drug development including (but not limited to):

Much of our work is with clinical stage drugs where preclinical support studies are high stakes and timely results are critical.

We integrate imaging modalities including:

  • PE/CT
  • SPECT/CT
  • CT
  • Micro-CT
  • MRI
  • Ultrasound
  • Optical (FLI and BLI)

with advanced computational imaging and analytics for drug quantification and PK, and bio-distribution.

Therapeutic and device areas include oncology, cardiovascular, CNS Receptor Occupancy, advanced multi compartmental Drug PK, and in vivo cell PK.

Capabilities include contract cyclotron and radiochemistry expertise to do C-11 and F-18 radiotracers as well as Lu-177, Zr-89, Y-90, and other tracers. To learn more about BioLaurus capabilities explore our web site or walk through our Capabilities slide deck.

Client Testimonials

Husam Younis
Husam Younis, PharmD, PhD Senior Director, Nonclinical Development

The BioLaurus “Can-Do” philosophy, flexibility, and agility with study design changes afforded the opportunity to conduct investigative studies that were not possible with other clinical research organizations.

Jeff Hsu
Jeff (Ssucheng) Hsu, PhD Director, Immuno-Pharmacology

Dr. Bourdon is a distinguished Bio-imaging expert with extensive experience and knowledge of imaging technologies. With great attention to detail, the study was only performed once, with all goals met – allowing for swift publication.

David Brewster
David Brewster, PhD, DABT VP and Global Head – Drug Safety Evaluation

Dr. Bourdon is a distinguished Bio-imaging expert with extensive experience and knowledge of imaging technologies. With great attention to detail, the study was only performed once, with all goals met – allowing for swift publication.

Request a Quote

Ready to learn more? Contact us to get a quote. We will respond within two business days. For faster service, please give us a call at the number below.

Services We Provide

Rat Brain CFN. Molecular Imaging Study

Molecular Imaging Services

BioLaurus is Your Solution for Molecular Imaging BioLaurus is a pre-clinical integrated molecular imaging research services provider to the biopharma ...
Read More
BLI HDTV Gene Delivery

Imaging Modalities

Imaging Modalities BioLaurus has a complete suite of image acquisition platforms or modalities designed to meet the needs of our ...
Read More
Researchers in lab coats

Support Facilities & Equipment

Support Facilities & Equipment BioLaurus has available a broad range of facilities and equipment to conduct molecular imaging and analytic ...
Read More